Pfizer Inc.
Anti-IL-33 antibodies, compositions, methods and uses thereof

Last updated:

Abstract:

The invention provides antibodies, and antigen-binding fragments thereof, that specifically bind to IL-33, as well as uses, and associated methods thereof.

Status:
Grant
Type:

Utility

Filling date:

24 Apr 2017

Issue date:

28 Jan 2020